We are grateful that the New York Times found and reported on our research regarding the TB dosing guidelines in patients with living with HIV, and the fact that our findings show that the dosage guidelines may indeed be too low. The article was published in April, 2018 and can be found here: https://www.nytimes.com/2018/04/06/health/tuberculosis-treatment-hiv.html
Personal Insights Blog
R4GH team members share their personal insights with interested readers in the Personal Insights Blog.
Antimicrobial resistance in urinary tract infections
The Urinary Tract Infection, Resistance, Antimicrobials, and Surveillance Project (URASP) aims to understand antimicrobial resistance in urinary tract infections by identifying the bacterial species and...
Gestational diabetes mellitus in HIV-infected women
Diabetes mellitus (DM) is one of the most common non-communicable diseases worldwide. The number of people with diabetes is increasing rapidly, especially in sub-Saharan Africa....
Strengthening capacity to optimally care for vulnerable groups at risk for sexually transmitted infections in Kampala, Uganda.
Sexually transmitted infections (STIs) are among the most common infectious diseases. The World Health Organization (WHO) estimates 340 million new cases of STIs occur annually,...